Stock Under $10 with 50-100% upside potential - 14 Days FREE!

China RTO Stocks Slide After China Media Bombshell

Stock quotes in this article: CCME, TSTC, CSKI, AOB, LIWA, BORN, IDI, ONP 

(Chinese reverse merger article updated from March 15.)

NEW YORK (TheStreet) -- A day after China MediaExpress (CCME) revealed that its former auditor believes the company is worthy of an investigation into possibly dubious accounting practices, a handful of small-cap Chinese stocks sold off sharply on Tuesday.

Fraud allegations have buffeted share prices among these names since last year, as more of the investing public begins to doubt the integrity -- rightly or wrongly -- of financial statements emanating from the People's Republic.

Of course, on Tuesday, the nuclear crisis in Japan and the broad and vicious slide in equities around the world didn't help Chinese small-cap names.

But more than a few of those stocks, most of which came public in the U.S. through a controversial process called a reverse merger, declined by more than 6% on heavy volumes during Tuesday's trading session. Many have been in the public eye before, accused of financial chicanery of one sort or another by short sellers.

Investigating Chinese Reverse Mergers

Shares of China Sky One Medical (CSKI), for example, a controversial maker of traditional Chinese homeopathic medicines, fell by as much as 21% before ending the session at $4.50, down 8%.

American Oriental Bioengineering (AOG), a competitor of China Sky's, issued poorly received first-quarter results Monday, earning a downgrade from Brean Murray, which is an accomplishment, since Brean Murray is one of a few small U.S. investment banks that do a robust business in the raising of capital and selling of shares in Chinese small-cap companies. The firm, in other words, has an interest in being bullish on Chinese stocks. AOB's beaten-down stock finished Tuesday at $1.83, surrendering 18%.

>>China Security CEO Talks Up LBO Again

Then there was China-Biotics, the Shanghai-based maker of yoghurt cultures, long suspected by short sellers of fictionalizing part of its business, including the number of retail outlets it has owned. (China-Biotics has denied all charges.) For the second time since the beginning of the year, the company has been the subject of an unfavorable investigative article in the Chinese press. This time it was the China Economic Review, an English-language monthly published out of Hong Kong, which posted on its web site a piece entitled "China-Biotics: The Numbers Don't Add Up." The stock declined 4% Tuesday.

Elsewhere, Telestone Technologies (TSTC), a network equipment maker which was aided in its reverse merger by a longtime promoter of Chinese stocks named S. Paul Kelley, surrendered 9% on no news.

Similarly, the small-cap beer brewer China New Borun (BORN), which went public through the front door in an initial public offering, dropped more than 18% before recovering Tuesday afternoon. The stock closed at $10.22, down 4.5%. China Education Alliance (CEU), another beaten-down name, waylaid by accusations of skullduggery, ended the Tuesday session by sinking 14% to $1.50 on more than double the daily average trading volume. The only news? The company, which sells Internet-based educational materials, had "successfully hosted" its third-annual "China Middle School Students Academic Abilities Competition" in Beijing. According to the company's press release, 300,000 grade schoolers attended.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%
US 10 Yr 1.949% +0.084

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs